ENDRA Life Sciences

NDRA

Market cap $5.77M

NDRA Hedge Fund Activity: Q1 2026 in Review

8 of the 8,141 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2026, worth a combined $417K — up 28% from $325K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NDRA positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $83.5K. The largest seller was Morgan Stanley, cutting an estimated $13.5K.

• 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2026, up from 7 in Q4 2025.
• Funds reported $417K of ENDRA Life Sciences stock for Q1 2026, up 28% quarter-over-quarter.
• 4 funds opened new ENDRA Life Sciences positions in Q1 2026 and 2 closed out, a net change of +2 holders.
• The largest ENDRA Life Sciences buyer in Q1 2026 was Geode Capital Management, an estimated $83.5K added.
• The largest ENDRA Life Sciences seller in Q1 2026 was Morgan Stanley, an estimated $13.5K sold.

Based on aggregated 13F filings for Q1 2026.